News
Our journalism is supported by our discerning readers. Purchases you make through our links may earn Guardian Nigeria a commission. After conducting an extensive three-month evaluation of Apollo.io ...
As wind turbines on the horizon churn out clean energy, John Smyth bends to stack damp peat - the cheap, smoky fuel he has ...
President Trump has been back in office for nearly four months and according to the New York Times, the president's approval ...
Otsuka's investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with ...
Carey's new CEO Alex Mirza plans an AI and loyalty overhaul to modernize limo service amid ride-sharing pressure.
Reform leader Nigel Farage is seen by voters to have more solid working class credentials than Prime Minister Sir Keir ...
Kerrigan Advisors sees buy-sell market staying strong in 2025, even as deal volume dips and tariff uncertainty lingers.
Non-doms have been leaving the country in their droves, according to experts. Here is a list of those we know have fled or ...
The Ontario Securities Commission (OSC) joined regulators from across the globe this week to crack-down on unauthorised finfluencers who are putting millions of social media users at risk by touting ...
All of the rival firms have hinted at plans beyond the current Eurostar map featuring Paris, Brussels, Amsterdam and Lille, ...
The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.
Canada's Sepset Biosciences Developing Point-of-Care Sepsis MDx With Eye Toward US Commercialization
The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results